Profile picture

Doctor Raluca Tomoaia

Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds (United Kingdom of Great Britain & Northern Ireland)
Membership: FESC Member EACVI Member
Follow
Logo ESC

Contributor content

Sex-based differences in masters athletes: insights from CPET and cardiac MRI analysis
Presentation
Sex-based differences in masters athletes: insights from CPET and cardiac MRI analysis
Gender-specific differences in embolic risk of infective endocarditis
Presentation
Gender-specific differences in embolic risk of infective endocarditis
Filamin-C variant-associated arrhythmogenic cardiomyopathy with LV involvement in a pregnant woman
Presentation
Filamin-C variant-associated arrhythmogenic cardiomyopathy with LV involvement in a pregnant woman
Myocardial remodelling and left ventricular recovery after guideline-directed medical therapy in non-ischaemic dilated cardiomyopathy
Presentation
Myocardial remodelling and left ventricular recovery after guideline-directed medical therapy in non-ischaemic dilated cardiomyopathy
Mechanisms affecting the neutrophil to lymphocyte ratio in heart failure: a prospective CMR study
Presentation
Mechanisms affecting the neutrophil to lymphocyte ratio in heart failure: a prospective CMR study
Mechanical atrial recovery by speckle-tracking echocardiography in the prediction of recurrence at 2 years after successful cardioversion of persistent atrial fibrillation
Presentation
Mechanical atrial recovery by speckle-tracking echocardiography in the prediction of recurrence at 2 years after successful cardioversion of persistent atrial fibrillation
Three-dimensional feature tracking cardiac magnetic resonance in hypertrophic cardiomyopathy: comparison with two-dimensional algorithm
Presentation
Three-dimensional feature tracking cardiac magnetic resonance in hypertrophic cardiomyopathy: comparison with two-dimensional algorithm
Gender differences in hypertrophic cardiomyopathy assessed by cardiovascular magnetic resonance feature tracking
Presentation
Gender differences in hypertrophic cardiomyopathy assessed by cardiovascular magnetic resonance feature tracking
Differences in the profile of patients with heart failure after STEMI compared to NSTEMI
Presentation
Differences in the profile of patients with heart failure after STEMI compared to NSTEMI
Troponin and NT-proBNP in the prediction of impaired myocardial deformation after STEMI
Presentation
Troponin and NT-proBNP in the prediction of impaired myocardial deformation after STEMI

ESC 365 is supported by